维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="Heideman L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines显示文摘	Wang W Heideman L Chung CS	2000	Mol Carcinog2000，28，2：	1
2	Cell cycle ar rest at G2/ M and growth inhibition by apigenin in human coloncarcinoma cell lines显示文摘	Wang W Heideman L Chung CS	2000	Mol Carcinog2000，28，2：	1
3	Localization patterns of plasma apolipoproteins in human atherosclerotic lesions显示文摘	Hoff H F Heideman C L Jackson R L	1975	Circ Res1975，37，1：	1
4	Understanding dioxin developmental toxicity using the zebrafish model 显示文摘	Carney S A Prasch A L Heideman W etal	2006	Birth Defects Research Part a-Clinical and Molecular Teratology2006，76，1：	1
5	Probing the magnetic field of light at optical frequencies显示文摘	Burresi M van Oosten D Kampfrath T Schoenmaker H Heideman R Leinse A Kuipers L		0，，5952：	1
6	Cell - cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines显示文摘	Wang W Heideman L Chung CS	2000	Mol Carcinog2000，28，2：	1
7	Cell - cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines显示文摘	Heideman L Chung CS et ad	2000	Mol Carcinog2000，28，2：	1
8	Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines显示文摘	Wang W Heideman L Chung CS	2000	Mol Carcinog2000，28，2：	1
9	Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines显示文摘	Wang W Heideman L Chung CS	2000	Mol Carcinog2000，28，2：	1
10	Retreatment with erlotinib:regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment显示文摘	Becker A Crombag L Heideman D A	2011	Eur J Cancer2011，47，17：	1
11	Retreatment with erlotinib: regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment 显示文摘	Becker A Crombag L Heideman D A M	2011	Eur J Cancer2011，47，17：	1
12	Cell cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines显示文摘	Wang W Heideman L Chung CS	2000	Mol Carcinog2000，28，2：	1
13	Incidence of T790M mutation in ( sequential ) rebiopsies in EGFR-mutated NSCLC-patients显示文摘	Kuiper J L Heideman D A M Thunnissen E	2014	Lung Cancer ( Amsterdam Netherlands )2014，85，1：	1
14	Effect of a minorphylline on cis-platin nephrotoxicity: Antioxidant system显示文摘	Heideman T H Muller S Y Mertins L	1995	Drug Chem Toxicol1995，18，：	1
15	Effect of a minorphylline on cisplatin nephrotoxicity:antioxidant system显示文摘	Muller ST Mertins L	1995	Drug Chem Toxicol1995，18，：	1
16	Cell-cycle arrest at GJM and growth inhibition by apigenin in human colon carcinoma cell lines 显示文摘	Wang W Heideman L Chung CS	2000	Mol Carcinog2000，28，2：	1
17	Cell2cycle arrest at G2PM andgrowth inhibition by apigenin in human colon carcinoma cell lines显示文摘	Wang W Heideman L Chung C S	2000	MolCarcinog2000，28，2：	1
18	Cell-cycle arrest at G2/M and growth inhibition by apigeninin human colon carcinoma cell lines显示文摘	Wang W Heideman L Chung C S	2000	Mol Carcinog2000，28，2：	1
19	Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines显示文摘	Wang W Heideman L Chung CS	2000	Mol Carcinog2000，28，2：	1
20	Cell- cycle arrest at G2/Mand grown inhibition by apigenin in human colon carcinoma celllines显示文摘	Wang W Heideman L Chung CS	2000	Mol Carcinog2000，28，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示